Cited by 548Multiple Sclerosis Research StudiesPsoriasis: Treatment and PathogenesisPolyomavirus and related diseases

The DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

Ramagopalan, Sreeram V, Dobson, Ruth, Meier, Ute C, Giovannoni, Gavin·2010·The Lancet Neurology

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is a common, complex neurological disease. The precise aetiology of MS is not yet known, although epidemiological data indicate that both genetic and environmental factors are important. The evidence that the environment acts long before MS becomes clinically evident is well established and suggests the existence of a prodromal phase for the disease. The increasing incidence of MS emphasises the need for strategies to prevent this chronic disorder, and the possibility of a prodrome indicates a window of opportunity to potentially reverse early disease processes before clinical disease becomes evident. Studying a prodrome requires techniques other than clinical observation such as monitoring endophenotypes that result from associated risk factors. However, our current knowledge of causal pathways and endophenotypes in MS is limited. Identifying and studying individuals with a high risk of developing the disease provides a powerful opportunity to understand the MS causal cascade and is highly relevant to strategies that are aimed at preventing this debilitating disease.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(10)70094-6

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Vitamin D Deficiency
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., LUBLIN, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,433
Multiple Sclerosis
Noseworthy, J. H., Lucchinetti, C. F., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 3,016
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
A Population-Based Study
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,899
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Sex differences in autoimmune disease
Whitacre, C. C. (2001) · Nature Immunology · doi:10.1038/ni0901-777 · Cited by 1,294
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251

Show all 155 references

Sorted by citations

Items 201–300 of 548

Progress in Mechanism of Astragalus membranaceus and Its Chemical Constituents on Multiple Sclerosis
Peng, Y., Deng, X., Yang, S., Nie, W., & Tang, Y.-D. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3535-6 · Cited by 21
Risk of fractures in patients with multiple sclerosis: record-linkage study
Ramagopalan, S. V., Seminog, O. O., Goldacre, R., & Goldacre, M. J. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-135 · Cited by 21
The challenges of UV-induced immunomodulation for children’s health
Norval, M. (2011) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2011.07.014 · Cited by 20
Multiple Sclerosis and Neurodegenerative Diseases
Gironi, M., Arnò, C., Comı, G., Pentón‐Rol, G., & Furlan, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803302-9.00004-x · Cited by 20
Multiple sclerosis in India: Iceberg or volcano
Zahoor, I., & Haq, E. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.03.015 · Cited by 21
Combined upper limb and breathing exercise programme for pain management in ambulatory and non-ambulatory multiple sclerosis individuals: part II analyses from feasibility study
Kezele, T. G., Babić, M., Kauzlarić-Živković, T., & Gulić, T. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04046-4 · Cited by 21
Mastery is associated with greater physical and mental health-related quality of life in two international cohorts of people with multiple sclerosis
O’Kearney, E., Brown, C. R., Jelinek, G. A., Neate, S. L., Taylor, K., Bevens, W., Livera, A. M. D., Simpson, S., & Weiland, T. J. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101481 · Cited by 21
Online Social Support for Patients with Multiple Sclerosis: A Thematic Analysis of Messages Posted to a Virtual Support Community.
Abbasi‐Shavazi, M., Morowatisharifabad, M. A., Shavazi, M. T. A., Mirzaei, M., & Mellat, A. (2016) · PubMed Central · Cited by 21
Epigenetic aspects of multiple sclerosis and future therapeutic options
Jamebozorgi, K., Rostami, D., Pormasoumi, H., Taghizadeh, E., Barreto, G. E., & Sahebkar, A. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1732974 · Cited by 22
Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.
Dake, M. D., Zivadinov, R., & Haacke, E. M. (2011) · Europe PMC (PubMed Central) · Cited by 20
MR imaging of the yucatan pig head and neck vasculature
Habib, C. A., Utriainen, D. T., Peduzzi-Nelson, J. D., Dawe, E., Mattei, J., Latif, Z., Casey, K., & Haacke, E. M. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24003 · Cited by 20
Angiogenic factors are associated with multiple sclerosis
Karampoor, S., Zahednasab, H., Ramagopalan, S. V., Mehrpour, M., & Keyvani, H. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.11.005 · Cited by 21
Microecologics and Exercise: Targeting the Microbiota–Gut–Brain Axis for Central Nervous System Disease Intervention
Peng, Z., Hou, T., Yang, K., Zhang, J., Mao, Y.-H., & Hou, X. (2025) · Nutrients · doi:10.3390/nu17111769 · Cited by 21
Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
Stürner, K. H., Siembab, I., Schön, G., Stellmann, J., Heidari, N., Fehse, B., Heesen, C., EIERMANN, T. H., Martinꝉ, R., & Binder, T. M. (2019) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217319894615 · Cited by 19
The major cause of multiple sclerosis is environmental: genetics has a minor role - No
Sawcer, S. J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511421106 · Cited by 19
The environmental risk factors in multiple sclerosis susceptibility: A case-control study
Shaygannejad, V., Rezaie, N., Paknahad, Z., Ashtari, F., & Maghzi, H. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.183665 · Cited by 19
Maternal and perinatal characteristics of infants who, later in life, developed multiple sclerosis: Record-linkage study
Goldacre, A., Pakpoor, J., & Goldacre, M. J. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.02.004 · Cited by 19
Is EBV the cause of multiple sclerosis?
Giovannoni, G., Hawkes, C. H., Lechner‐Scott, J., Levy, M., Yeh, E. A., & Gold, J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103636 · Cited by 19
Molecular Interventions towards Multiple Sclerosis Treatment
Metaxakis, A., Petratou, D., & Tavernarakis, N. (2020) · Brain Sciences · doi:10.3390/brainsci10050299 · Cited by 18
Gut human microbiota and multiple sclerosis
Kozhieva, M. K., Melnikov, M., Rogovskii, V., Oleskin, A. V., Kabilov, M. R., & Boyko, A. N. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201711710211-19 · Cited by 18
Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells
Disanto, G., Sandve, G. K., Berlanga‐Taylor, A. J., Morahan, J. M., Dobson, R., Giovannoni, G., & Ramagopalan, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032281 · Cited by 18
Month of birth and risk of multiple sclerosis in Kuwait: A population-based registry study
Akhtar, S., Alroughani, R., AlShammari, A. M., Al-Abkal, J., & Ayad, Y. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514541578 · Cited by 18
Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis
Sombekke, M. H., van der Voort, L., Kragt, J. J., Nielsen, J., Guzel, H., Visser, A., Oudejans, C. B. M., Crusius, J. B. A., Peña, A. S., Vrenken, H., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511402411 · Cited by 18
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
Hamid, K. M., Nejati, A., Shoja, Z., Mollaei‐Kandelous, Y., Doosti, R., Mirshafiey, A., Tafakhori, A., Sahraian, M. A., & Marashi, S. M. (2016) · PubMed · Cited by 18
Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions
Navarro, A., Rioseras, B., del Valle, E., Martínez‐Pinilla, E., Astudillo, A., & Tolivia, J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00254 · Cited by 18
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis
Disanto, G., Hall, C., Lucas, R. M., Ponsonby, A., Berlanga‐Taylor, A. J., Giovannoni, G., Ramagopalan, S. V., the Ausimmune Investigator Group, Chapman, C., Coulthard, A., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513477231 · Cited by 18
Synthesis of a Bifunctional Peptide Inhibitor–IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis
White, D. R., Khedri, Z., Kiptoo, P. K., Siahaan, T. J., & Tolbert, T. J. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00175 · Cited by 18
The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities
Afrasiabi, A., Ahlenstiel, C., Swaminathan, S., & Parnell, G. P. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1454 · Cited by 19
MRI characteristics of familial and sporadic multiple sclerosis patients
Tipirneni, A., Weinstock‐Guttman, B., Ramanathan, M. K., Abdelrahman, N. G., Hussein, S. M., Hagemeier, J., Durfee, J., Teter, B. E., Hojnacki, D. W., Dwyer, M. G., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512469697 · Cited by 17
Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients
Haghighi, S., Lekman, A. Y., Nilsson, S., Blomqvist, M., & Andersen, O. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.01.007 · Cited by 17
The Refinement of Genetic Predictors of Multiple Sclerosis
Disanto, G., Dobson, R., Pakpoor, J., Elangovan, R. I., Adiutori, R., Kühle, J., & Giovannoni, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096578 · Cited by 16
Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study
Pereira, W. L. D. C. J., Flauzino, T., Alfieri, D. F., Oliveira, S. R., Kallaur, A. P., Simão, A. N. C., Lozovoy, M. A. B., Kaimen-Maciel, D. R., Maes, M. H. J., & Reiche, E. M. V. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116630 · Cited by 18
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort
Ramien, C., Pachnio, A., Sisay, S., Begum, J., Leese, A. M., Disanto, G., Kühle, J., Giovannoni, G., Rickinson, A. B., Ramagopalan, S. V., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513509507 · Cited by 16
Diet quality is not associated with late-onset multiple sclerosis risk– A Danish Cohort Study
Pommerich, U. M., Nielsen, R. O., Overvad, K., Dahm, C. C., Tjønneland, A. M., Olsen, A., & Dalgas, U. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.101968 · Cited by 16
Diffusion-derived parameters in lesions, peri-lesion and normal-appearing white matter in multiple sclerosis using tensor, kurtosis and fixel-based analysis
van der Weijden, C. W. J., van der Hoorn, A., Potze, J. H., Renken, R. J., Borra, R., Dierckx, R., Gutmann, I. W., Ouaalam, H., Karimi, D., Gholipour, A., et al. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221107953 · Cited by 16
Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review
Wahbeh, F., Restifo, D., Laws, S., Pawar, A., & Parikh, N. S. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.02.013 · Cited by 16
A Risk Score for Predicting Multiple Sclerosis
Dobson, R., Ramagopalan, S. V., Topping, J. H., Smith, P. G., Solanky, B., Schmierer, K., Chard, D., & Giovannoni, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164992 · Cited by 15
Clinical trials in multiple sclerosis: potential future trial designs
Manouchehri, N., Zhang, Y., Salter, A. R., Hussain, R. Z., Hartung, H.-P., Hemmer, B., Linker, R. A., Segal, B. M., Cutter, G., & Stüve, O. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419847095 · Cited by 17
Real-world experience of ocrelizumab initiation in a diverse multiple sclerosis population
Coban, H., Germaine, S., Dimaandal, I., Haberli, N., Padam, C., Creed, M., & Imitola, J. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103021 · Cited by 21
Development of a Research Agenda for Evaluation of Interventional Therapies for Chronic Cerebrospinal Venous Insufficiency: Proceedings from a Multidisciplinary Research Consensus Panel
Siskin, G. P., Haskal, Z. J., McLennan, G., Dake, M. D., Haacke, E. M., McDonald, S., Royal, W., Vedantham, S., Hubbard, D., Sclafani, S. J. A., et al. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2011.03.007 · Cited by 15
Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer
Rafe, M. R. (2023) · Nanotheranostics · doi:10.7150/ntno.88849 · Cited by 16
Assessment of Outcome Predictors after First Attack of Optic Neuritis
Mamarabadi, M., Razjouyan, H., Mohammadi, F., & Moghaddasi, M. (2011) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012488 · Cited by 15
Effects of Oenothera biennis L. and Hypericum perforatum L. extracts on some central nervous system myelin proteins, brain histopathology and oxidative stress in mice with experimental autoimmune encephalomyelitis
Selek, Ş., Eşrefoğlu, M., Meral, İ., Bulut, H., Caglar, H., Sonuc, G., Yildiz, C., Teloglu, E. S., Doğan, N., Yuce, B., et al. (2019) · Biotechnic & Histochemistry · doi:10.1080/10520295.2018.1482001 · Cited by 15
Disease Modifying Therapy in Multiple Sclerosis
Williams, U. E., Oparah, S. K., & Philip-Ephraim, E. E. (2014) · International Scholarly Research Notices · doi:10.1155/2014/307064 · Cited by 15
Protective association of VDR gene polymorphisms and haplotypes with multiple sclerosis patients in Egyptian population
Hassab, A. H., Deif, A. H., Elneely, D., Tawadros, I. M., & Fayad, A. I. (2019) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-019-0009-2 · Cited by 15
A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
El-Muzaini, H., Akhtar, S., & Alroughani, R. (2020) · BMC Neurology · doi:10.1186/s12883-020-01635-1 · Cited by 15
The interplay of multiple sclerosis and menstrual cycle: Which one affects the other one?
Mirmosayyeb, O., Badihian, S., Manouchehri, N., Basiri, A., Barzegar, M., Esmaeil, N., Fayyazi, E., & Shaygannejad, V. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.01.020 · Cited by 15
Current therapies for neurological disorders and their limitations
Rezaei, S., Morshedi, K., Shafabakhsh, R., & Mahjoubin‐Tehran, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824467-8.00009-7 · Cited by 14
25-hydroxyvitamin D Concentrations in Patients with Optic Neuritis as a Clinically Isolated Syndrome and Healthy Controls.
Etemadifar, M., Abtahi, S.-H., Razmjoo, H., Abtahi, M.-A., Dehghani, A., Salari, M., Maghzi, A., & Akbari, M. (2012) · Europe PMC (PubMed Central) · Cited by 14
Treatment Update in Multiple Sclerosis
Morris, K. A., & Yiannikas, C. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0256-5 · Cited by 14
Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases
Brütting, C., Emmer, A., Kornhuber, M. E., & Staege, M. S. (2017) · BioMed Research International · doi:10.1155/2017/7973165 · Cited by 14
Identifying the culprits in neurological autoimmune diseases
Acosta‐Ampudia, Y., Monsalve, D. M., & Ramı́rez-Santana, C. (2019) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2019.100015 · Cited by 15
Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia
Lasalvia, P., Hernández, F., Castañeda‐Cardona, C., Cuestas, J. A., & Rosselli, D. (2020) · Value in Health Regional Issues · doi:10.1016/j.vhri.2019.08.481 · Cited by 14
High birth weight and risk of multiple sclerosis: A multicentre study in Argentina
Luetic, G. G., Menichini, M. L., Deri, N. H., Steinberg, J. D., Carrá, A., Cristiano, E., Patrucco, L., Curbelo, M. C., & Rojas, J. I. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102628 · Cited by 14
Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner
Oreja‐Guevara, C., Wiendl, H., Kieseier, B. C., Airas, L. M., & for the NeuroNet Study Group (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613501575 · Cited by 14
The Relationship between Body Image, Disability and Mental Health in Patients with Multiple Sclerosis
Buono, V. L., Bonanno, L., Corallo, F., Cardile, D., D’Aleo, G., Rifici, C., Sessa, E., Quartarone, A., & Cola, M. C. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103606 · Cited by 13
Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis: History and Background
Dake, M. D. (2012) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2012.02.002 · Cited by 14
Month of birth and risk of multiple sclerosis in a Portuguese population
Barros, P., de Sá, J. M., & Sá, M. J. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.04.007 · Cited by 13
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases
Matas, S. L. D. A., von Glehn, F., Fernandes, G. B. P., & Soares, C. A. S. (2013) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20130151 · Cited by 13
Vitamin D and Multiple Sclerosis: An Update
Zahoor, I., & Haq, E. (2017) · Codon Publications eBooks · doi:10.15586/codon.multiplesclerosis.2017.ch5 · Cited by 13
Spinal Cord Injury Is Related to an Increased Risk of Multiple Sclerosis: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study
Lin, C.-W., Huang, Y., & Pan, S. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3723 · Cited by 14
Randomised Clinical Trial Comparing the Efficacy of A Gluten-Free Diet Versus A Regular Diet in A Series of Relapsing-Remitting Multiple Sclerosis Patients
Rodrigo, L. (2014) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/1/1/1012 · Cited by 13
The Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies
Tamanini, J. V. G., Sabino, J. V., Cordeiro, R. A., Mizubuti, V., Villarinho, L. D. L., Duarte, J. Á., Pereira, F. V., Appenzeller, S., Damasceno, A., & Reis, F. (2023) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2023.03.017 · Cited by 14
Could Mathematics be the Key to Unlocking the Mysteries of Multiple Sclerosis?
Weatherley, G. R., Araujo, R. P., Dando, S. J., & Jenner, A. L. (2023) · Bulletin of Mathematical Biology · doi:10.1007/s11538-023-01181-0 · Cited by 13
Nootropics: Phytochemicals with Neuroprotective and Neurocognitive Enhancing Properties
Crespo-Bujosa, H. B., & Rodríguez, R. L. F. S. (2019) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2019.3.9 · Cited by 12
Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population
Huang, Y.-C., Chien, W., Chung, C., Chang, H., Kao, Y., Wan, F.-J., Huang, S.-H., Chung, R., Wang, R. S., Wang, B., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s268360 · Cited by 13
Vascular pathology of multiple sclerosis
Zivadinov, R., Alexander, S., & Minagar, A. (2012) · Neurological Research · doi:10.1179/0161641212z.000000000114 · Cited by 12
Investigation of cytocrom c oxidase gene subunits expression on the Multiple sclerosis
Zaefizadeh, M., Safavizadeh, N., & Rahmani, S. (2013) · Indian Journal of Human Genetics · doi:10.4103/0971-6866.112879 · Cited by 12
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Bahar, M., Ashtari, F., Aghaei, M., Akbari, M., Salari, M., & Ghalamkari, S. (2012) · PubMed · Cited by 12
Correlation between vitamin D and alterations in MRI among patients with multiple sclerosis
Piędel, F., Rocka, A. A., Piwek, M., Jasielski, P. P., Petit, V., & Rejdak, K. (2020) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/127062 · Cited by 12
The effect of lesion filling on brain network analysis in multiple sclerosis using structural magnetic resonance imaging
van der Weijden, C. W. J., Pitombeira, M. S., Haveman, Y. R. A., Sánchez-Catasús, C. A., Campanholo, K. R., Kolinger, G. D., Rimkus, C. D. M., Buchpiguel, C. A., Dierckx, R., Renken, R. J., et al. (2022) · Insights into Imaging · doi:10.1186/s13244-022-01198-4 · Cited by 13
Neurodegenerative Disorders and the Gut-Microbiome-Brain Axis: A Literature Review
Dandamudi, B. J., Dimaano, K. A. M., Shah, N., AlQassab, O., Al-Sulaitti, Z., Nelakuditi, B., & Mohammed, L. (2024) · Cureus · doi:10.7759/cureus.72427 · Cited by 17
The relationship between HERVs and exogenous viral infections: A focus on the value of HERVs in disease prediction and treatment
Dou, A., Xu, J., & Zhou, C. (2025) · Virulence · doi:10.1080/21505594.2025.2523888 · Cited by 11
Disentangling the molecular mechanisms of multiple sclerosis: The contribution of twin studies
Buscarinu, M. C., Fornasiero, A., Ferraldeschi, M., Romano, S., Reniè, R., Morena, E., Romano, C., Pellicciari, G., Landi, A. C., Fagnani, C., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.024 · Cited by 11
How long is the presymptomatic phase of multiple sclerosis?
Giovannoni, G. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.02.010 · Cited by 11
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach
Mohammadbeigi, A., Kazemitabaee, M., & Etemadifar, M. (2016) · Archives of Women s Mental Health · doi:10.1007/s00737-016-0600-1 · Cited by 11
Effect of comorbidities on the course of multiple sclerosis
Puz, P., Lasek‐Bal, A., Stęposz, A., Bartoszek, K., & Radecka, P. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.02.014 · Cited by 11
Treatment Considerations in the Radiologically Isolated Syndrome
Makhani, N. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-0608-8 · Cited by 12
Cross-Cultural Adaptation and Validation of the Physical Disability Resiliency Scale in a Sample of Chinese With Physical Disability
Duan, W., Mu, W., & Xiong, H. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.602736 · Cited by 11
Central nervous system inflammation across the age span
Bar‐Or, A., & Antel, J. P. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000331 · Cited by 11
Hepcidin and metallothioneins as molecular base for sex-dependent differences in clinical course of experimental autoimmune encephalomyelitis in chronic iron overload
Ćurko‐Cofek, B., Kezele, T. G., & Barac-Latas, V. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.07.022 · Cited by 12
Pericytes in Multiple Sclerosis
Rivera, F. J., Hinrichsen, B., & Silva, M. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16908-4_8 · Cited by 11
Myelin Imaging of the Spinal Cord in Animal Models and Patients with Multiple Sclerosis Using [ 11 C]MeDAS PET: A Translational Study
van der Weijden, C. W. J., Ahmed, A. K. M. A., van der Hoorn, A., Zhu, J., Wu, C., Wang, Y., Stormezand, G. N., Dierckx, R. A. J. O., Meilof, J. F., & de Vries, E. F. J. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266896 · Cited by 10
Design, methodological issues and participation in a multiple sclerosis case–control study
Williamson, D., Marrie, R., Ashley-Koch, A., Schiffer, R., Trottier, J., & Wagner, L. (2012) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01629.x · Cited by 9
Vitamin D as a clinical biomarker in multiple sclerosis
Carlson, N. G., & ROSE, J. W. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.772978 · Cited by 10
Molecular Detection of Epstein–Barr Virus, Human Herpes Virus 6, Cytomegalovirus, and Hepatitis B Virus in Patients with Multiple Sclerosis
Asouri, M., Sahraian, M. A., Karimpoor, M., Fattahi, S., Motamed, N., Doosti, R., Amirbozorgi, G., Sadaghiani, S., Mahboudi, F., & Akhavan‐Niaki, H. (2020) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2020.179 · Cited by 10
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis
Shaghayegh, H. J. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/466 · Cited by 10
Season of birth and multiple sclerosis in Tunisia
Sidhom, Y., Kacem, I., Bayoudh, L., Djebara, M. B., Hizem, Y., Abdelfettah, S. B., Gargouri, A., & Gouider, R. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.08.002 · Cited by 10
Advances in polysaccharides from traditional Chinese medicine for the treatment of central nervous system disorders: A comprehensive review
Song, F., Mei, Z., & Zhang, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149416 · Cited by 9
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
Mechelli, R., Umeton, R., Manfrè, G., Romano, S., Buscarinu, M. C., Rinaldi, V., Bellucci, G., Bigi, R., Ferraldeschi, M., Salvetti, M., et al. (2020) · Genes · doi:10.3390/genes11010097 · Cited by 9
Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies
Mortazavi, M., Hizarci, Ö., Gerdes, L. A., Havla, J. B., Kümpfel, T., Hohlfeld, R., Stoecklein, S., Keeser, D., & Ertl-Wagner, B. B. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102734 · Cited by 10
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis
Ganesh, A., & Stahnisch, F. W. (2013) · European Neurology · doi:10.1159/000348780 · Cited by 9
Protein-Protein Interaction Analysis Highlights Additional Loci of Interest for Multiple Sclerosis
Ragnedda, G., Disanto, G., Giovannoni, G., Ebers, G. C., Sotgiu, S., & Ramagopalan, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046730 · Cited by 9
Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis
Creanza, T. M., Liguori, M., Liuni, S., Nuzziello, N., & Ancona, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060936 · Cited by 10
Investigation of image-derived input functions for non-invasive quantification of myelin density using [11C]MeDAS PET
van der Weijden, C. W. J., van der Hoorn, A., Wang, Y., Willemsen, A. T. M., Dierckx, R., Lammertsma, A. A., & de Vries, E. F. J. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119772 · Cited by 9
Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis
Ramagopalan, S. V., Giovannoni, G., Yeates, D., Seagroatt, V. A., & Goldacre, M. J. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512450627 · Cited by 9
Seizure characteristics in multiple sclerosis patients.
Shaygannejad, V., Ashtari, F., Zare, M., Ghasemi, M., Norouzi, R., & Maghzi, H. (2013) · Europe PMC (PubMed Central) · Cited by 9
JAK-STAT Lodges in Multiple Sclerosis: Pathophysiology and Therapeutic Approach Overview
Hamid, K. M., Isiyaku, A., Kalgo, M. U., Yahaya, I. S., & Mirshafiey, A. (2017) · OALib · doi:10.4236/oalib.1103492 · Cited by 10
miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta
Tahmasebivand, M., Mousavi, S. R., Khorrami, M., Ayromlou, H., Rikhtegar, R., Saberi, L., Khademi, B., Bahmanpour, Z., & Emamalizadeh, B. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577212 · Cited by 9
How Early Is Early Multiple Sclerosis?
Lorenzo, S. S. D., Bakirtzis, C., Konstantinidou, N., Kesidou, E., Parissis, D., Evangelopoulos, M., Elsayed, D., Hamdy, E., Said, S., & Grigoriadis, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010214 · Cited by 8

Authors: Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G.
Affiliations: Centre for Human Genetics (GB)
Queen Mary University of London (GB)
Corresponding author: Giovannoni, Gavin
ORCID: Ramagopalan, Sreeram V
Dobson, Ruth
Meier, Ute C
Giovannoni, Gavin
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2010-07
Volume: 9
Issue: 7
Pages: 727-739
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(10)70094-6
OpenAlex: W2149134458
Cited by: 548
References: 155
Citations by year: 2026: 18 · 2025: 25 · 2024: 19 · 2023: 33 · 2022: 38 · 2021: 33 · 2020: 32 · 2019: 36 · 2018: 24 · 2017: 39 · 2016: 39 · 2015: 31 · 2014: 38 · 2013: 41 · 2012: 49
FWCI: 5.57
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Rea Charitable Trust
Medical Research Council
National Multiple Sclerosis Society
Aims2Cure
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
Keywords: multiple sclerosis, risk factors, prodromal symptoms, etiology, causal pathways, endophenotypes, genetic factors, environmental factors, disease prevention, MS incidence
MeSH terms: Disease Susceptibility, Environment, Environmental Exposure, Humans, Multiple Sclerosis, Risk Factors, Sex Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks